Ningbo MedicalSystem Biotechnology Co Ltd (300439) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥48.96 Million ≈ $7.16 Million USD) by net assets (CN¥2.95 Billion ≈ $431.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300439 equity financing ratio to measure how much of total assets are equity-financed.

Ningbo MedicalSystem Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Ningbo MedicalSystem Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ningbo MedicalSystem Biotechnology Co Lt cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Ningbo MedicalSystem Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ningbo MedicalSystem Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Huali Industries SHG:603038	-0.005x
Zhejiang Sf Oilless Bearing Co Ltd SHE:300817	0.053x
Semco Technologies Sas PA:ALSEM	N/A
PostNL NV AS:PNL	0.754x
Core Laboratories NV NYSE:CLB	0.014x
DukSan Neolux Co.Ltd KQ:213420	0.043x
Grid Dynamics Holdings Inc NASDAQ:GDYN	0.016x
Aprogen KIC Inc KO:007460	-0.041x

Annual Cash Flow Conversion Efficiency for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Ningbo MedicalSystem Biotechnology Co Lt market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.93 Billion ≈ $429.26 Million	CN¥397.81 Million ≈ $58.21 Million	0.136x	-42.06%
2023-12-31	CN¥2.71 Billion ≈ $396.07 Million	CN¥633.53 Million ≈ $92.71 Million	0.234x	+4.43%
2022-12-31	CN¥2.52 Billion ≈ $368.67 Million	CN¥564.67 Million ≈ $82.63 Million	0.224x	+3.95%
2021-12-31	CN¥2.39 Billion ≈ $349.84 Million	CN¥515.48 Million ≈ $75.43 Million	0.216x	-60.12%
2020-12-31	CN¥1.69 Billion ≈ $246.86 Million	CN¥912.07 Million ≈ $133.47 Million	0.541x	+24.86%
2019-12-31	CN¥1.39 Billion ≈ $203.16 Million	CN¥601.17 Million ≈ $87.97 Million	0.433x	+134.69%
2018-12-31	CN¥2.27 Billion ≈ $332.15 Million	CN¥418.80 Million ≈ $61.28 Million	0.185x	+428.61%
2017-12-31	CN¥2.29 Billion ≈ $334.63 Million	CN¥-128.40 Million ≈ $-18.79 Million	-0.056x	-4283.55%
2016-12-31	CN¥1.83 Billion ≈ $267.53 Million	CN¥2.45 Million ≈ $359.05K	0.001x	-99.03%
2015-12-31	CN¥1.29 Billion ≈ $188.39 Million	CN¥177.55 Million ≈ $25.98 Million	0.138x	-50.86%
2014-12-31	CN¥415.13 Million ≈ $60.75 Million	CN¥116.51 Million ≈ $17.05 Million	0.281x	-13.52%
2013-12-31	CN¥308.32 Million ≈ $45.12 Million	CN¥100.06 Million ≈ $14.64 Million	0.325x	+40.55%
2012-12-31	CN¥202.58 Million ≈ $29.64 Million	CN¥46.78 Million ≈ $6.85 Million	0.231x	-48.63%
2011-12-31	CN¥110.84 Million ≈ $16.22 Million	CN¥49.82 Million ≈ $7.29 Million	0.450x	--

About Ningbo MedicalSystem Biotechnology Co Ltd

SHE:300439 China Diagnostics & Research

Market Cap

$493.77 Million

CN¥3.37 Billion CNY

Market Cap Rank

#12143 Global

#3476 in China

Share Price

CN¥8.78

Change (1 day)

+1.62%

52-Week Range

CN¥8.01 - CN¥11.87

All Time High

CN¥49.34